Literature DB >> 24237858

Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study.

Yufang Bi1, Jieli Lu, Weiqing Wang, Yiming Mu, Jiajun Zhao, Chao Liu, Lulu Chen, Lixin Shi, Qiang Li, Qin Wan, Shengli Wu, Tao Yang, Li Yan, Yan Liu, Guixia Wang, Zuojie Luo, Xulei Tang, Gang Chen, Yanan Huo, Zhengnan Gao, Qing Su, Zhen Ye, Youming Wang, Guijun Qin, Huacong Deng, Xuefeng Yu, Feixia Shen, Li Chen, Liebin Zhao, Jie Zhang, Jichao Sun, Meng Dai, Min Xu, Yu Xu, Yuhong Chen, Shenghan Lai, Zachary T Bloomgarden, Donghui Li, Guang Ning.   

Abstract

OBJECTIVE: To demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism.
METHODS: Between 2011 and 2012, 259 657 community-dwelling adults, aged 40 years and older, were recruited from 25 centers across mainland China to participant in the baseline survey of the REACTION study, with follow-up investigations performed 3, 5, and 10 years later. Detailed questionnaires about lifestyles, physical and biochemical measurement, bio-samples including serum, urine, and whole blood for DNA extraction were collected for all the participants.
RESULTS: The mean ± standard deviation (SD) age of this cohort was 57 ± 10 years. And the prevalence of pre-existing and newly diagnosed diabetes was 10.32% and 10.57%, respectively. A total of 4511 prevalent cancer cases (988 men and 3523 women) were identified, the prevalence was 1.79. Compared to those with normal glucose metabolism, men with diabetes had a significantly lower adjusted prevalence ratio (PR) of stomach cancer (PR: 0.38, 95% CI: 0.16-0.89), and women with diabetes had significantly higher adjusted PRs of cancer of all sites (PR: 1.36, 95% CI: 1.20-1.56), and cancer of the breast (PR: 1.56, 95% CI: 1.21-2.00), the endometrium (PR: 1.58, 95% CI: 1.16-2.15), and the thyroid (PR: 1.53, 95% CI: 1.03-2.27).
CONCLUSION: The multi-center REACTION study has captured a broad range of data on physical, psychological and metabolic function as well as health status, biochemical and lifestyle information in 259 657 adults from the general population across the China.
© 2013 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  REACTION study; cancer; diabetes; 肿瘤,糖尿病,REACTION研究

Mesh:

Substances:

Year:  2014        PMID: 24237858     DOI: 10.1111/1753-0407.12108

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  67 in total

1.  Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence?

Authors:  X Ma; Y-L Zhang; Q Ji; Y Xing; H Pan; S Chen; J-L Tang; S Zhu
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

2.  Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.

Authors:  Hongmei Zhang; Yixin Niu; Hongxia Gu; Shuai Lu; Weiwei Zhang; Xiaoyong Li; Zhen Yang; Li Qin; Qing Su
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

3.  Type 2 diabetes is causally associated with depression: a Mendelian randomization analysis.

Authors:  Liping Xuan; Zhiyun Zhao; Xu Jia; Yanan Hou; Tiange Wang; Mian Li; Jieli Lu; Yu Xu; Yuhong Chen; Lu Qi; Weiqing Wang; Yufang Bi; Min Xu
Journal:  Front Med       Date:  2018-11-16       Impact factor: 4.592

4.  Sex difference in the association between habitual daytime napping and prevalence of diabetes: a population-based study.

Authors:  Kan Sun; Feng Li; Yiqin Qi; Diaozhu Lin; Meng Ren; Mingtong Xu; Fangping Li; Yan Li; Li Yan
Journal:  Endocrine       Date:  2015-10-20       Impact factor: 3.633

5.  Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women.

Authors:  Wanwan Sun; Jieli Lu; Shengli Wu; Yufang Bi; Yiming Mu; Jiajun Zhao; Chao Liu; Lulu Chen; Lixin Shi; Qiang Li; Tao Yang; Li Yan; Qin Wan; Yan Liu; Guixia Wang; Zuojie Luo; Xulei Tang; Gang Chen; Yanan Huo; Zhengnan Gao; Qing Su; Zhen Ye; Youmin Wang; Guijun Qin; Huacong Deng; Xuefeng Yu; Feixia Shen; Li Chen; Liebin Zhao; Tiange Wang; Jichao Sun; Min Xu; Yu Xu; Yuhong Chen; Meng Dai; Jie Zhang; Di Zhang; Shenghan Lai; Donghui Li; Guang Ning; Weiqing Wang
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

6.  Low serum free thyroxine concentrations associate with increased arterial stiffness in euthyroid subjects: a population-based cross-sectional study.

Authors:  Jian Wang; Xuqin Zheng; Min Sun; Zhixiao Wang; Qi Fu; Yun Shi; Mengdie Cao; Zhenxin Zhu; Chuchen Meng; Jia Mao; Fan Yang; Xiaoping Huang; Jingjing Xu; Hongwen Zhou; Yu Duan; Wei He; Mei Zhang; Tao Yang
Journal:  Endocrine       Date:  2015-05-19       Impact factor: 3.633

7.  Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study.

Authors:  Pijun Yan; Yong Xu; Ying Miao; Xue Bai; Yuru Wu; Qian Tang; Zhihong Zhang; Jiong Yang; Qin Wan
Journal:  Acta Diabetol       Date:  2021-06-28       Impact factor: 4.280

8.  The association of menstrual and reproductive factors with thyroid nodules in Chinese women older than 40 years of age.

Authors:  Kun Wang; Yu Yang; Yang Wu; Jie Chen; Danyu Zhang; Chao Liu
Journal:  Endocrine       Date:  2014-07-11       Impact factor: 3.633

9.  Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based Chinese adults aged 40 years or older.

Authors:  Kai Liang; Yu Sun; Wen-juan Li; Xiu-ping Zhang; Cheng-qiao Li; Wei-fang Yang; Ze-qiang Ma; Ai-xia Ma; Hui-zhen Zheng; Jun Song; Peng Lin; Xin-guo Hou; Li Chen
Journal:  Diabetes Technol Ther       Date:  2014-07-11       Impact factor: 6.118

10.  Machine Learning For Tuning, Selection, And Ensemble Of Multiple Risk Scores For Predicting Type 2 Diabetes.

Authors:  Yujia Liu; Shangyuan Ye; Xianchao Xiao; Chenglin Sun; Gang Wang; Guixia Wang; Bo Zhang
Journal:  Risk Manag Healthc Policy       Date:  2019-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.